OSCR:NYE-Oscar Health Inc (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 13.54

Change

-0.10 (-0.73)%

Market Cap

USD 4.12B

Volume

4.33M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-08 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

+9.44 (+1.53%)

USD 566.72B
ELV Elevance Health Inc

+2.77 (+0.66%)

USD 95.26B
CNC Centene Corp

+0.60 (+1.00%)

USD 30.37B
MOH Molina Healthcare Inc

-1.06 (-0.32%)

USD 18.86B
NEUE NeueHealth Inc

-0.04 (-0.79%)

USD 0.05B
CI Cigna Corp

+23.29 (+7.28%)

N/A
CVS CVS Health Corp

+0.27 (+0.49%)

N/A
HUM Humana Inc

-5.68 (-1.97%)

N/A

ETFs Containing OSCR

DDOC:F Global X Telemedicine & D.. 4.27 % 0.00 %

N/A

USD 4.62M
DDOC:XETRA Global X Telemedicine & D.. 0.00 % 0.00 %

+0.22 (+0.00%)

USD 5.39M

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 47.98% 100% F 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 47.98% 100% F 88% B+
Trailing 12 Months  
Capital Gain 90.44% 100% F 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 90.44% 100% F 90% A-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 38.58% 100% F 91% A-
Dividend Return 38.58% 100% F 90% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 107.90% 13% F 8% B-
Risk Adjusted Return 35.76% 63% D 53% F
Market Capitalization 4.12B 33% F 76% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector